In this video, Jay Chhablani, MD, discusses findings presented at the ARVO meeting from a phase 2b study evaluating suprachoroidal axitinib for neovascular age-related macular degeneration.

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Better understanding how humpbacks and other whales see could inspire “strategies for making fishing gear more visible” and ...

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...

At ARVO 2025, in Salt Lake City, Utah, Peng Shang, PhD, talked about her presentation on how the Y402H polymorphism of ...

Despite having big eyes, the whales can't make out details of objects more than a few body lengths away, according to a new ...

By doing so, retinols can help prevent and soften wrinkles, smooth uneven skin texture and improve skin complexion.” For ...

The breakdown of glutamine is an important metabolic pathway for the health and survival of rod photoreceptors within the retina.

Tinlarebant has previously been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug Designation in the U.S., Europe, and Japan, and the Pioneer Drug Designation in ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...